vx-407
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 17, 2024 (NCT06345755)
Timeline
Indications
Mechanism of action
- Polycystin-1INHIBITOR
PKD1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07161037 | Phase 2 | Oct 23, 2025 | Vertex |
| NCT07074327 | Phase 1 | Jul 11, 2025 | Vertex |
| NCT07022119 | Phase 1 | Jun 12, 2025 | Vertex |
| NCT06345755 | Phase 1 | Apr 17, 2024 | Vertex |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vertex | For profit | 4 | 4 | 2 | 2024 |
1 organizations
Page 1 / 1